Procter & Gamble SEC Filings

The Procter & Gamble Company proxy statement describes board and governance practices, executive compensation design, and planned leadership transition. The Board comprises an independent majority and conducts annual director elections, regular executive sessions, and ongoing shareholder engagement including 75+ meetings in 2024-25. The compensation program emphasizes pay-for-performance with multi-year equity (PSPs, LTIP, RSUs), diversified performance metrics (organic sales growth, core EPS, operating profit, free cash flow) and a Relative TSR multiplier. The Compensation & Leadership Development Committee sets peer benchmarks, engages an independent consultant, enforces share ownership and clawback policies, and discloses that the 2024-25 Say-on-Pay received over 90% support. The filing notes a $1.0 billion after-tax impairment charge related to Gillette intangible assets and describes insider trading, related-person transaction, and equity plan provisions.

Form 144 notice for Procter & Gamble Company (PG) shows a proposed sale of 1,000 shares of common stock through Morgan Stanley Smith Barney, with an aggregate market value of $156,460. The filer reports acquiring 15,811 shares as a Performance Stock Program Award from Procter & Gamble and intends the sale approximately on 08/29/2025. The filing also discloses that the filer sold 6,167 shares for gross proceeds of $969,907.53. The notice includes the signed representation that the seller is unaware of undisclosed material adverse information about the issuer.

Procter & Gamble officer Moses Aguilar reported acquisitions of company common stock and restricted stock units. On 08/19/2025 he acquired 15,314 shares at $0 under the issuer's 2019 Stock and Incentive Compensation Plan, bringing his total direct beneficial ownership to 40,841.1704 shares. Additional indirect holdings include 6,750.7456 shares held by a retirement plan trustee and 428.6033 shares held by a Mexico international stock ownership plan trustee. The filing notes the report was late due to an inadvertent administrative error.

Insider sale to cover taxes. Procter & Gamble officer Sundar G. Raman reported a sale of 9,554 shares of PG on 08/21/2025 at an average price of $158.1589 per share to cover taxes related to a stock award. Following the reported sale the filing shows 41,886.4892 shares held directly and an additional 8,366.3969 shares held indirectly through a retirement plan trustee. The Form 4 was signed via attorney-in-fact on 08/22/2025. The filing identifies the reporting person as an officer (CEO-Fabric & Home Care).

Gary A. Coombe, an officer (CEO - Grooming) of Procter & Gamble Co (PG), reported a sale of 10,194 shares of P&G common stock on 08/21/2025 at a price of $158.159 per share. After the sale, Mr. Coombe's direct beneficial ownership is reported as 34,978.145 shares. He also reports indirect holdings of 477.661 shares held by a retirement plan trustee and 1,295.35 shares held in an International Stock Ownership Plan and Pension Plan (Switzerland). The filing states the shares were sold to cover taxes on a stock award. The form was signed by an attorney-in-fact on behalf of Mr. Coombe on 08/22/2025.

Keith R. Alexandra, listed as an officer (CEO - Beauty) and director of Procter & Gamble Co. (PG), reported stock sales on 08/21/2025. The Form 4 shows two non-derivative sale transactions: 10,697 shares sold at $158.159 and 766 shares sold at $158.1593, with an explanatory note stating the shares were sold to cover taxes on a stock award. Following the transactions, the filing reports 27,529.5056 shares held directly and several indirect holdings totaling 11,371.947 shares (4,895.7069; 4,408.4867; 2,562.2551) across spouse and retirement plan trustee accounts. The Form 4 is signed by an attorney-in-fact on 08/22/2025.

Jennifer L. Davis, identified as CEO - Health Care and an officer of Procter & Gamble Co. (PG), reported a sale of company stock on 08/19/2025. The filing shows a non-derivative transaction where 8,596 shares were sold at a price of $157.2738 per share, with the form noting the sale was to cover taxes on a stock award. After the sale, Ms. Davis is reported to directly beneficially own 64,990.9326 shares and indirectly beneficially own 15,401.6828 shares through a retirement plan trustee. The form was signed by an attorney-in-fact on 08/21/2025.

Susan Street Whaley, Chief Legal Officer and Secretary of Procter & Gamble Company (PG), reported changes in her beneficial ownership through Form 4 filings executed by attorney-in-fact. On 08/18/2025 she was awarded 15,811 shares under the issuer's 2019 Stock and Incentive Compensation Plan at no cash price, increasing her reported holdings; dividend equivalents in the form of RSUs were included in the total. On 08/19/2025 she sold 6,167 shares at an average price of $157.2738 per share to cover taxes related to the award. The filing also shows 6,477.4515 shares indirectly held by a retirement plan trustee and RSU units that will deliver shares on retirement. The Form 4 was signed on behalf of Ms. Whaley by an attorney-in-fact on 08/20/2025.

Andre Schulten, Chief Financial Officer of Procter & Gamble (PG), reported changes in beneficial ownership. On 08/18/2025 he received a stock award of 27,924 shares under the company's 2019 Stock and Incentive Compensation Plan, which included dividend equivalents in the form of RSUs. On 08/19/2025 he sold 11,638 shares at $157.2738 to cover taxes. Following these transactions the filing shows 52,642.0273 shares held directly and 6,813.5641 shares held indirectly by a retirement plan trustee. The filing also reports 22.5445 RSUs granted 08/15/2025 that convert to common stock on retirement.